Sanofi's “Badge of Honor,” made with FCB Health New York, won gold for Data-Driven Campaign of the Year among suppliers, ...

Sanofi’s ‘A Trusted Circle,’ made with Republica Havas Health, won bronze for Purpose-led Campaign of the Year among ...

Novavax on Thursday provided preliminary adjusted revenue for 2026 and pushed back its profitability target by a year to 2028 ...

Accenture, Sanofi, and Dell Technologies stand out in today's top analyst research picks, each navigating growth and market ...

Zacks spotlights fresh research on Accenture, Sanofi, and Dell Technologies, revealing trends in consulting, pharma, and ...

A recently launched campaign starring patients and scientists shows Sanofi in hot pursuit of scientific innovation. | A ...

Achieved additional $75 million in partnering proceeds from Sanofi and GileadGranted license to additional preclinical program to Gilead that ...

Sanofi remporte cette année la palme du champion climatique du CAC40, selon une analyse réalisée par Les Ateliers du futur.

Regeneron and Sanofi’s Dupixent trial shows major improvement in allergic fungal rhinosinusitis symptoms in patients 6+. Read ...

Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a ...

Sanofi (ENXTPA:SAN) has caught the attention of investors lately, especially as its stock has seen gradual movement over the past month. Shares are currently trading at €85.44, which reflects a subtle ...

The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organization (CDSCO), has approved ...